SKP2 and colorectal carcinoma: To begin, in silico analyses of TCGA data revealed that SKP2 copy number losses occur in 10.8% of CRC cases, are associated with reduced expression (mRNA), and correspond with worse progression-free survival, while worse survival outcomes were not observed for patient samples exhibiting SKP2 copy number gains or mutations.